BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12967779)

  • 1. Can tolerogenic dendritic cells help to modulate allo-immune responses in the setting of hematopoietic cell transplantation?
    Fresnay S; Garnache-Ottou F; Plumas J; Seilles E; Tiberghien P; Saas P
    Transpl Immunol; 2003; 11(3-4):259-66. PubMed ID: 12967779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provision of antifungal immunity and concomitant alloantigen tolerization by conditioned dendritic cells in experimental hematopoietic transplantation.
    Montagnoli C; Perruccio K; Bozza S; Bonifazi P; Zelante T; De Luca A; Moretti S; D'Angelo C; Bistoni F; Martelli M; Aversa F; Velardi A; Romani L
    Blood Cells Mol Dis; 2008; 40(1):55-62. PubMed ID: 17827038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation.
    Arpinati M; Chirumbolo G; Urbini B; Bonifazi F; Bandini G; Saunthararajah Y; Zagnoli A; Stanzani M; Falcioni S; Perrone G; Tura S; Baccarani M; Rondelli D
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):106-15. PubMed ID: 14750076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
    Foss FM
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic HLA mismatched/ haploidentical hematopoietic stem cell transplantation].
    Wu JY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):73-7. PubMed ID: 17650664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in allogeneic hematopoietic stem cell transplantation--not just a case for effector cells.
    Troeger A; Meisel R; Moritz T; Dilloo D
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S59-64. PubMed ID: 15812533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics.
    Porta MD; Rigolin GM; Alessandrino EP; Maiocchi M; Malcovati L; Vanelli L; Baratè C; Rumi E; Ciccone M; Cuneo A; Lazzarino M; Castoldi G
    Eur J Haematol; 2004 Jan; 72(1):18-25. PubMed ID: 14962258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast appearance of donor dendritic cells in human skin: dynamics of skin and blood dendritic cells after allogeneic hematopoietic cell transplantation.
    Auffermann-Gretzinger S; Eger L; Bornhäuser M; Schäkel K; Oelschlaegel U; Schaich M; Illmer T; Thiede C; Ehninger G
    Transplantation; 2006 Mar; 81(6):866-73. PubMed ID: 16570010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predominant immature CD8alpha+ dendritic cells prevent graft-vs.-host disease but do not increase the risk of leukemia recurrence.
    Xu L; Duan L; Cao K; Yuan G; Peng Y; Huang X; Xiang P; Li S
    Eur J Haematol; 2007 Mar; 78(3):235-45. PubMed ID: 17253973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
    Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo selection of recipient-type alloantigen-specific CD4(+)CD25(+) immunoregulatory T cells for the control of graft-versus-host disease after allogeneic hematopoietic stem-cell transplantation.
    Trenado A; Fisson S; Braunberger E; Klatzmann D; Salomon BL; Cohen JL
    Transplantation; 2004 Jan; 77(1 Suppl):S32-4. PubMed ID: 14726768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive role of donor strain immature dendritic cells in the creation of allograft tolerance.
    Kim YS; Yang SH; Kang HG; Seong EY; Lee SH; Gao W; Kenny J; Zheng XX; Strom TB
    Int Immunol; 2006 Dec; 18(12):1771-7. PubMed ID: 17068105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients.
    Boeck S; Hamann M; Pihusch V; Heller T; Diem H; Rolf B; Pihusch R; Kolb HJ; Pihusch M
    Bone Marrow Transplant; 2006 Jan; 37(1):57-64. PubMed ID: 16258529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell homeostasis and trafficking in transplantation.
    Merad M; Collin M; Bromberg J
    Trends Immunol; 2007 Aug; 28(8):353-9. PubMed ID: 17618832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of glucocorticoid-induced leucine zipper (GILZ) expression by dendritic cells in tolerance induction.
    Krzysiek R
    Transplant Proc; 2010 Oct; 42(8):3331-2. PubMed ID: 20970683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of tolerogenic dendritic cells for transplantation.
    Morelli AE; Hackstein H; Thomson AW
    Semin Immunol; 2001 Oct; 13(5):323-35. PubMed ID: 11502167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating dendritic cell subset levels after allogeneic stem cell transplantation in children correlate with time post transplant and severity of acute graft-versus-host disease.
    Vakkila J; Thomson AW; Hovi L; Vettenranta K; Saarinen-Pihkala UM
    Bone Marrow Transplant; 2005 Mar; 35(5):501-7. PubMed ID: 15665841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell recipients do not develop post-transplantation immune tolerance to antigens present on minimal residual disease.
    Natzke AM; Shaw JL; McKeller MR; Emo KL; Mullen CA
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):34-45. PubMed ID: 17222751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.